These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 9927265)

  • 1. Recurrent Clostridium difficile disease: epidemiology and clinical characteristics.
    McFarland LV; Surawicz CM; Rubin M; Fekety R; Elmer GW; Greenberg RN
    Infect Control Hosp Epidemiol; 1999 Jan; 20(1):43-50. PubMed ID: 9927265
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictors of first recurrence in Clostridium difficile-associated disease. A study of 306 patients hospitalized in a Romanian tertiary referral center.
    Lupse M; Flonta M; Cioara A; Filipescu I; Todor N
    J Gastrointestin Liver Dis; 2013 Dec; 22(4):397-403. PubMed ID: 24369321
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcomes of Clostridium difficile-associated disease treated with metronidazole or vancomycin before and after the emergence of NAP1/027.
    Pépin J; Valiquette L; Gagnon S; Routhier S; Brazeau I
    Am J Gastroenterol; 2007 Dec; 102(12):2781-8. PubMed ID: 17900327
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management and outcomes of a first recurrence of Clostridium difficile-associated disease in Quebec, Canada.
    Pépin J; Routhier S; Gagnon S; Brazeau I
    Clin Infect Dis; 2006 Mar; 42(6):758-64. PubMed ID: 16477549
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Past, present, and future therapies for Clostridium difficile-associated disease.
    Surowiec D; Kuyumjian AG; Wynd MA; Cicogna CE
    Ann Pharmacother; 2006 Dec; 40(12):2155-63. PubMed ID: 17148650
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proton pump inhibitor use and recurrent Clostridium difficile-associated disease: a case-control analysis matched by propensity score.
    Kim YG; Graham DY; Jang BI
    J Clin Gastroenterol; 2012; 46(5):397-400. PubMed ID: 22298089
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A retrospective review of metronidazole and vancomycin in the management of Clostridium difficile infection in patients with hematologic malignancies.
    Parmar SR; Bhatt V; Yang J; Zhang Q; Schuster M
    J Oncol Pharm Pract; 2014 Jun; 20(3):172-82. PubMed ID: 23804627
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibiotic treatment for Clostridium difficile-associated diarrhea in adults.
    Nelson R
    Cochrane Database Syst Rev; 2007 Jul; (3):CD004610. PubMed ID: 17636768
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Breaking the cycle: treatment strategies for 163 cases of recurrent Clostridium difficile disease.
    McFarland LV; Elmer GW; Surawicz CM
    Am J Gastroenterol; 2002 Jul; 97(7):1769-75. PubMed ID: 12135033
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clostridium difficile-associated diarrhea in a region of Quebec from 1991 to 2003: a changing pattern of disease severity.
    Pépin J; Valiquette L; Alary ME; Villemure P; Pelletier A; Forget K; Pépin K; Chouinard D
    CMAJ; 2004 Aug; 171(5):466-72. PubMed ID: 15337727
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of vancomycin and metronidazole for the treatment of Clostridium difficile-associated diarrhea, stratified by disease severity.
    Zar FA; Bakkanagari SR; Moorthi KM; Davis MB
    Clin Infect Dis; 2007 Aug; 45(3):302-7. PubMed ID: 17599306
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clostridium difficile-associated diarrhea: risk factors, diagnostic methods, and treatment.
    Oldfield EC
    Rev Gastroenterol Disord; 2004; 4(4):186-95. PubMed ID: 15580153
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The changing face of Clostridium difficile: what treatment options remain?
    Shen EP; Surawicz CM
    Am J Gastroenterol; 2007 Dec; 102(12):2789-92. PubMed ID: 18042108
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New advances in Clostridium difficile infection: changing epidemiology, diagnosis, treatment and control.
    DuPont HL; Garey K; Caeiro JP; Jiang ZD
    Curr Opin Infect Dis; 2008 Oct; 21(5):500-7. PubMed ID: 18725800
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recurrent Clostridium difficile infection: a review of risk factors, treatments, and outcomes.
    Johnson S
    J Infect; 2009 Jun; 58(6):403-10. PubMed ID: 19394704
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Case-control study of antibiotic use and subsequent Clostridium difficile-associated diarrhea in hospitalized patients.
    Baxter R; Ray GT; Fireman BH
    Infect Control Hosp Epidemiol; 2008 Jan; 29(1):44-50. PubMed ID: 18171186
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment strategies for C. difficile associated diarrhea.
    Stepan C; Surawicz CM
    Acta Gastroenterol Latinoam; 2007 Sep; 37(3):183-91. PubMed ID: 17955730
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nosocomial diarrhoea in adult medical patients: the role of Clostridium difficile in a North Italian acute care teaching hospital.
    Sansone S; Aschbacher R; Staffler M; Bombonato M; Girardi F; Larcher C; Wiedermann CJ
    J Prev Med Hyg; 2009 Jun; 50(2):117-20. PubMed ID: 20099443
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Epidemiology of Clostridium difficile-associated disease (CDAD) in Salamanca].
    Siller-Ruiz M; Calvo-García N; Hernández-Egido S; María-Blázquez A; de Frutos-Serna M; García-Sánchez JE
    Rev Esp Quimioter; 2014 Jun; 27(2):122-6. PubMed ID: 24940894
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibiotic treatment for Clostridium difficile-associated diarrhea in adults.
    Bricker E; Garg R; Nelson R; Loza A; Novak T; Hansen J
    Cochrane Database Syst Rev; 2005 Jan; (1):CD004610. PubMed ID: 15674956
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.